Kathrine Røe Redalen
Kathrine Røe Redalen
Associate professor, Norwegian University of Science and Technology
Adresse e-mail validée de medisin.uio.no
Titre
Citée par
Citée par
Année
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1 H …
T Seierstad, K Røe, B Sitter, J Halgunset, K Flatmark, AH Ree, DR Olsen, ...
Molecular Cancer 7 (1), 33, 2008
462008
Superparamagnetic magnetite nanoparticles for cancer theranostics
A Kleinauskas, JK Kim, GH Choi, HT Kim, K Røe, P Juzenas
Reviews in Nanoscience and Nanotechnology 1 (4), 271-283, 2012
392012
Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal …
T Seierstad, K Røe, DR Olsen
Radiotherapy and Oncology 85 (2), 187-194, 2007
372007
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
S Folkvord, K Flatmark, T Seierstad, K Røe, H Rasmussen, AH Ree
Radiotherapy and Oncology 86 (3), 428-434, 2008
352008
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice
T Seierstad, S Folkvord, K Røe, K Flatmark, A Skretting, DR Olsen
Neoplasia 9 (5), 392-400, 2007
352007
Preclinical dynamic 18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis
K Røe, TB Aleksandersen, A Kristian, LB Nilsen, T Seierstad, H Qu, ...
Acta oncologica 49 (7), 914-921, 2010
312010
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
HB Ragnum, K Røe, R Holm, L Vlatkovic, JM Nesland, EK Aarnes, ...
International Journal of Radiation Oncology* Biology* Physics 87 (4), 753-760, 2013
292013
Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study
K Røe, M Kakar, T Seierstad, AH Ree, DR Olsen
Radiation oncology 6 (1), 1-9, 2011
292011
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF (V600E) and BRAF wild-type metastatic malignant melanoma
A Tahiri, K Røe, AH Ree, R de Wijn, K Risberg, C Busch, PE Lønning, ...
PLoS One 8 (8), e72692, 2013
262013
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
K Røe, LTG Mikalsen, AJ van der Kogel, J Bussink, H Lyng, AH Ree, ...
Radiation oncology 7 (1), 75, 2012
252012
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
E Hagtvet, K Røe, DR Olsen
Radiation Oncology 6 (1), 135, 2011
252011
MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer
T Seierstad, KH Hole, KK Grøholt, S Dueland, AH Ree, K Flatmark, ...
The British journal of radiology 88 (1051), 20150097, 2015
242015
Personalized radiotherapy: concepts, biomarkers and trial design
AH Ree, KR Redalen
The British journal of radiology 88 (1051), 20150009, 2015
242015
Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival
KM Bakke, KH Hole, S Dueland, KK Grøholt, K Flatmark, AH Ree, ...
Acta Oncologica 56 (6), 813-818, 2017
182017
Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
HH Hektoen, K Flatmark, Y Andersson, S Dueland, KR Redalen, AH Ree
BMC cancer 15 (1), 543, 2015
162015
Construction of a modified capacitive overlap MR coil for imaging of small animals and objects in a clinical whole-body scanner
T Seierstad, K Røe, B Høvik
Physics in Medicine & Biology 52 (22), N513, 2007
162007
An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer
T Bjørnetrø, KR Redalen, S Meltzer, NS Thusyanthan, R Samiappan, ...
Journal of extracellular vesicles 8 (1), 1567219, 2019
152019
Dynamic multi‐echo DCE‐ and DSC‐MRI in rectal cancer: Low primary tumor Ktrans and peak are significantly associated with lymph node metastasis
E Grøvik, KR Redalen, TH Storås, A Negård, SH Holmedal, AH Ree, ...
Journal of Magnetic Resonance Imaging 46 (1), 194-206, 2017
152017
Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
S Meltzer, E Kalanxhi, HH Hektoen, S Dueland, K Flatmark, KR Redalen, ...
Oncotarget 7 (23), 34907, 2016
152016
Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
ME Revheim, K Røe, ØS Bruland, T Bach-Gansmo, A Skretting, ...
Molecular imaging and biology 13 (6), 1234-1240, 2011
152011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20